Perspective Therapeutics (CATX) Change in Acquisitions & Divestments (2015 - 2026)

Perspective Therapeutics' Change in Acquisitions & Divestments history runs 10 years deep, the most recent figure standing at $47.6 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 119.5% year-over-year to $47.6 million; the TTM figure through Mar 2026 stood at $25.9 million (down 74.18% YoY), while the FY2024 annual figure was $78.7 million, up 245.85% from the prior year.
• Change in Acquisitions & Divestments came in at $47.6 million for Q1 2026 at Perspective Therapeutics, up from -$119.7 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $49.8 million in Q2 2025 to a low of -$119.7 million in Q4 2025.
• A 5-year average of $18.0 million and a median of $38.2 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments slumped 395.45% in 2025 and soared 119.5% in 2026, its largest moves.
• Perspective Therapeutics' Change in Acquisitions & Divestments stood at $12.5 million in 2022, then surged by 81.56% to $22.8 million in 2023, then surged by 77.93% to $40.5 million in 2024, then plunged by 395.45% to -$119.7 million in 2025, then jumped by 139.81% to $47.6 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $47.6 million, -$119.7 million, and $48.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison